Thermodynamic characterization of amyloid polymorphism by microfluidic transient incomplete separation DOI Creative Commons
Azad Farzadfard, Antonín Kunka, Thomas O. Mason

et al.

Chemical Science, Journal Year: 2024, Volume and Issue: 15(7), P. 2528 - 2544

Published: Jan. 1, 2024

Amyloid fibrils of proteins such as α-synuclein are a hallmark neurodegenerative diseases and much research has focused on their kinetics mechanisms formation. The question to the thermodynamic stability structures received less attention. Here, we newly utilize principle transient incomplete separation species in laminar flow combination with chemical depolymerization for quantification amyloid fibril stability. relative concentrations monomer at equilibrium determined through an

Language: Английский

Cryo-EM structures of amyloid-β 42 filaments from human brains DOI
Yang Yang, Diana Arseni, Wenjuan Zhang

et al.

Science, Journal Year: 2022, Volume and Issue: 375(6577), P. 167 - 172

Published: Jan. 14, 2022

Hi-res view of human Aβ42 filaments Alzheimer’s disease is characterized by a loss memory and other cognitive functions the filamentous assembly Aβ tau in brain. The peptides into that end at residue 42 central event. Yang et al . used electron cryo–electron microscopy to determine structures from brain (see Perspective Willem Fändrich). They identified two types related S-shaped filaments, each consisting identical protofilaments. These will inform development better vitro animal models, inhibitors assembly, imaging agents with increased specificity sensitivity. —SMH

Language: Английский

Citations

360

Structures of α-synuclein filaments from human brains with Lewy pathology DOI
Yang Yang, Yang Shi, Manuel Schweighauser

et al.

Nature, Journal Year: 2022, Volume and Issue: 610(7933), P. 791 - 795

Published: Sept. 15, 2022

Language: Английский

Citations

286

Neuropathology and molecular diagnosis of Synucleinopathies DOI Creative Commons
Shunsuke Koga, Hiroaki Sekiya, Naveen Kondru

et al.

Molecular Neurodegeneration, Journal Year: 2021, Volume and Issue: 16(1)

Published: Dec. 18, 2021

Synucleinopathies are clinically and pathologically heterogeneous disorders characterized by pathologic aggregates of α-synuclein in neurons glia, the form Lewy bodies, neurites, neuronal cytoplasmic inclusions, glial inclusions. can be divided into two major disease entities: body multiple system atrophy (MSA). Common clinical presentations Parkinson's (PD), PD with dementia, dementia bodies (DLB), while MSA has subtypes, predominant cerebellar ataxia parkinsonism. There currently no disease-modifying therapies for synucleinopathies, but information obtained from molecular genetics models that explore mechanisms conversion to oligomers insoluble fibrils offer hope eventual therapies. It remains unclear how associated distinct cellular pathologies (e.g., inclusions) what factors determine neuroanatomical cell type vulnerability. Accumulating evidence vitro vivo experiments suggests species derived "strains" having different seeding properties. Recent advancements assays, such as real-time quaking-induced (RT-QuIC) protein misfolding cyclic amplification (PMCA), not only demonstrate activity also exciting opportunities diagnosis using readily accessible peripheral tissue samples. Cryogenic electron microscopy (cryo-EM) structural studies recombinant or brain-derived filaments provide new insight synucleinopathies. In this review, we describe clinical, genetic neuropathologic features including a discussion evolution classification staging disease. We brief on proposed formation, well supporting existence strains MSA.

Language: Английский

Citations

211

Assembly of recombinant tau into filaments identical to those of Alzheimer’s disease and chronic traumatic encephalopathy DOI Creative Commons
Sofia Lövestam,

Fujiet Adrian Koh,

Bart van Knippenberg

et al.

eLife, Journal Year: 2022, Volume and Issue: 11

Published: March 4, 2022

Abundant filamentous inclusions of tau are characteristic more than 20 neurodegenerative diseases that collectively termed tauopathies. Electron cryo-microscopy (cryo-EM) structures amyloid filaments from human brain revealed distinct folds characterise many different diseases. A lack laboratory-based model systems to generate these has hampered efforts uncover the molecular mechanisms underlie Here, we report in vitro assembly conditions with recombinant replicate both Alzheimer's disease (AD) and chronic traumatic encephalopathy (CTE), as determined by cryo-EM. Our results suggest post-translational modifications modulate filament assembly, previously observed additional densities AD CTE may arise presence inorganic salts, like phosphates sodium chloride. In into disease-relevant will facilitate studies determine their roles diseases, well development compounds specifically bind or prevent formation.

Language: Английский

Citations

211

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies DOI Creative Commons
Ayami Okuzumi, Taku Hatano, Gen Matsumoto

et al.

Nature Medicine, Journal Year: 2023, Volume and Issue: 29(6), P. 1448 - 1455

Published: May 29, 2023

Abnormal α-synuclein aggregation is a key pathological feature of group neurodegenerative diseases known as synucleinopathies, which include Parkinson's disease (PD), dementia with Lewy bodies and multiple system atrophy (MSA). The pathogenic β-sheet seed conformation found in various tissues, suggesting potential biomarker, but few studies have been able to reliably detect these seeds serum samples. In this study, we developed modified assay system, called immunoprecipitation-based real-time quaking-induced conversion (IP/RT-QuIC), enables the detection individuals synucleinopathies. our internal first second cohorts, IP/RT-QuIC showed high diagnostic performance for differentiating PD versus controls (area under curve (AUC): 0.96 (95% confidence interval (CI) 0.95-0.99)/AUC: 0.93 CI 0.84-1.00)) MSA (AUC: 0.64 0.49-0.79)/AUC: 0.73 0.49-0.98)). also 0.86 0.74-0.99)) 0.80 0.65-0.97)) from blinded external cohort. Notably, amplified maintained disease-specific properties, allowing differentiation samples MSA. summary, here present novel platform that may allow synucleinopathies using

Language: Английский

Citations

174

Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids DOI Creative Commons
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder

et al.

Chemical Reviews, Journal Year: 2021, Volume and Issue: 121(13), P. 8285 - 8307

Published: June 17, 2021

This review will focus on the process of amyloid-type protein aggregation. Amyloid fibrils are an important hallmark misfolding diseases and therefore have been investigated for decades. Only recently, however, atomic or near-atomic resolution structures elucidated from various in vitro ex vivo obtained fibrils. In parallel, fibril formation has studied under highly artificial but comparatively reproducible conditions. The starts with a summary what is known speculated aggregation experiments. A partially hypothetic selection model be described that may suitable to explain why amyloid look way they do, particular, at least all so far reported high cryo-electron microscopy register, cross-β-sheet mostly consist two protofilaments twisted around each other. An intrinsic feature prion-like nature assemblies. Transferring point view situation not straightforward, hypothetic, leaves many open questions need addressed future.

Language: Английский

Citations

158

Mechanisms and pathology of protein misfolding and aggregation DOI
Nikolaos Louros, Joost Schymkowitz, Frédéric Rousseau

et al.

Nature Reviews Molecular Cell Biology, Journal Year: 2023, Volume and Issue: 24(12), P. 912 - 933

Published: Sept. 8, 2023

Language: Английский

Citations

122

Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids DOI
Sjors H. W. Scheres, Benjamin Falcon, Michel Goedert

et al.

Nature, Journal Year: 2023, Volume and Issue: 621(7980), P. 701 - 710

Published: Sept. 27, 2023

Language: Английский

Citations

120

Disease-specific tau filaments assemble via polymorphic intermediates DOI Creative Commons
Sofia Lövestam, David Li,

Jane L. Wagstaff

et al.

Nature, Journal Year: 2023, Volume and Issue: 625(7993), P. 119 - 125

Published: Nov. 29, 2023

Abstract Intermediate species in the assembly of amyloid filaments are believed to play a central role neurodegenerative diseases and may constitute important targets for therapeutic intervention 1,2 . However, structural information about intermediate has been scarce molecular mechanisms by which amyloids assemble remain largely unknown. Here we use time-resolved cryogenic electron microscopy study vitro recombinant truncated tau (amino acid residues 297–391) into paired helical Alzheimer’s disease or chronic traumatic encephalopathy 3 We report formation shared first filament, with an ordered core comprising 302–316. Nuclear magnetic resonance indicates that same adopt rigid, β-strand-like conformations monomeric tau. At later time points, disappears observe many different filaments, structures depend on reaction conditions. end both reactions, most disappear cores as those from human brains remain. Our results provide insights processes primary secondary nucleation assembly, implications design new therapies.

Language: Английский

Citations

84

Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases DOI
Dan Li, Cong Liu

Nature reviews. Neuroscience, Journal Year: 2022, Volume and Issue: 23(9), P. 523 - 534

Published: May 30, 2022

Language: Английский

Citations

80